ArticleRSC advances2025
Graphene oxide - polymer nanocomposites for efficient water hardness removal: a step towards healthier drinking water.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A new, non-toxic, environmentally friendly nanocomposite, based on graphene oxide and biopolymers was developed as an effective adsorbent for water hardness removal. Graphene oxide was synthesized by a modified Hummers' method, whereas crosslinked carboxymethyl cellulose (CMC) and chitosan were used as biopolymers. Montmorillonite (MMT) was utilized as an additive to enhance the adsorbent's performance. The solubility and adsorption behaviours of the prepared materials were investigated in respect to calcium ions (Ca
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.